Mariner’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
117,130
-1,086
-0.9% -$36.5K ﹤0.01% 1109
2026
Q1
$4.24M Sell
118,216
-114,374
-49% -$2.96M 0.01% 1121
2025
Q4
$4.62M Sell
232,590
-136,818
-37% -$2.63M 0.01% 1037
2025
Q3
$6.74M Buy
369,408
+334,544
+960% +$5.5M 0.01% 792
2025
Q2
$549K Buy
34,864
+3,986
+13% +$50.7K ﹤0.01% 2258
2025
Q1
$392K Sell
30,878
-1,102
-3% -$17.3K ﹤0.01% 2398
2024
Q4
$704K Buy
31,980
+16,127
+102% +$339K ﹤0.01% 1900
2024
Q3
$283K Buy
+15,853
New +$254K ﹤0.01% 2625
2024
Q2
Sell
-13,317
Closed -$198K 3191
2024
Q1
$198K Sell
13,317
-1
-0% -$16 ﹤0.01% 2777
2023
Q4
$238K Buy
+13,318
New +$216K ﹤0.01% 2542

Other funds holding CLMT

Mariner's CLMT Position: Q2 2026 in Review

Mariner reduced its Calumet Specialty Products (CLMT) stake by 0.92% in Q2 2026, selling an estimated $36.5K and leaving 117,130 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

Mariner first reported a position in CLMT in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.74M in Q3 2025. 189 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Mariner held 117,130 shares of Calumet Specialty Products worth $4.22M as of Q2 2026.
  • Mariner sold 1,086 Calumet Specialty Products shares in Q2 2026, an estimated $36.5K.
  • Calumet Specialty Products made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1109 holding.
  • Mariner first reported a position in Calumet Specialty Products in Q4 2023 and has held it in 10 quarters since.
  • Mariner's Calumet Specialty Products position peaked at $6.74M in Q3 2025.
  • 189 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.